Condition
ABO Incompatibility
Total Trials
5
Recruiting
1
Active
1
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Completed2
Enrolling By Invitation1
Withdrawn1
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT06921330Not ApplicableCompleted
White Cover & Massage Effects on Bilirubin and Phototherapy in ABO-Incompatible Newborns
NCT07273448Enrolling By InvitationPrimary
Study on the Clinical Outcomes of ABO-Incompatible Living Donor Liver Transplantation
NCT06502847Completed
The Role of Breastmilk and Serum Exosomes in Neonatal Jaundice Due to ABO Incompatibility
NCT05581745Not ApplicableRecruiting
A2 to O Lung Transplants
NCT00917007WithdrawnPrimary
Measurement of Carboxyhemoglobin by Gas Chromatography as an Index of Hemolysis
Showing all 5 trials